Imran leads Bayer’s Open Innovation Center for the East Coast, and is responsible for early access to technology and co-creation of new companies. Intrapreneur driving external innovation with entrepreneurs. Drives several mentoring & partnering programs he created at Bayer. Imran is an outcomes driven biopharmaceutical leader, recognized for delivering innovation and being creative, dynamic, and cross functionally capable. Recipient of Boehringer Ingelheim's President Award. Extensive experience covering business development, alliance management, partnering and licensing activities in diagnostics, personalized medicine, therapeutics, and technology platforms with proven track record from Boehringer Ingelheim, Massbio, Genzyme Genetics, Millennium Pharmaceuticals. Possess strong business acumen, critical thinking, negotiations and sophisticated quantitative tools to illuminate business and technology opportunities, structure and negotiate deals, analyze intellectual property and understand financial exposure for drug development programs, technology platforms and new diagnostic services. Proven in negotiation and execution of complex agreements with biopharmaceutical, academic, and government entities enhancing R&D performance, acquiring strategic assets and accelerating product and service launches, covering purchases, collaborations, clinical trials, platform technologies and others. Demonstrable track record at Boehringer Ingelheim, Genzyme Genetics, Millennium Pharmaceuticals, MassBio, Dana Farber Cancer Center and Mayo Clinic. Founded BI Grass Roots Innovation programs – BI Office Hours, BI Academy, and BI Innovation Prize. Additionally, founded Massbio’s Pharma Days and MassConnect, a start-up mentoring service. Additionally, founded PharmaDays, a MassBio partnering service connecting major pharmaceutical companies with biotechnology and the academic community for one-on-one partnering.